PPMI News

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

Tests for Parkinson's within Reach

August 15, 2018

Parkinson's scientists say tests to predict the course of the disease are within reach thanks to investment in large-scale studies and standardized methods.

Learn more
Summit Outlines Needs to Advance Parkinson's Cures

June 20, 2018

The Michael J. Fox Foundation gathered leaders from industry, academia, non-profits and government to discuss the way forward in Parkinson's drug trials.

Learn more
Collaboration with Verily Aims to Deepen Parkinson's Understanding through Digital Health Tools

May 9, 2018

The Michael J. Fox Foundation and Verily are outfitting more than 800 study participants with wearable devices to better understand and track disease to add a new dimension of health data to the PPMI.

Learn more
Using Our Heritage to Find a Cure for Parkinson's Disease

April 25, 2018

PPMI participant and guest blogger, Barbara Robinson, MD, shares her journey with PD.

Learn more
New Reports Measure Parkinson's Motor Progression

March 28, 2018

Findings from two studies supported by The Michael J. Fox Foundation report how Parkinson's motor symptoms progress in distinct patient populations.

Learn more
Ask the MD: Parkinson's Diagnosis and Biomarkers

March 22, 2018

In the latest “Ask the MD” video, Dr. Dolhun talks about how doctors diagnose Parkinson’s and how a tool called a biomarker may help.

Learn more
Parkinson's Protein Levels Stable over Year in Early Disease

October 13, 2017

Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.

Learn more